Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function
Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin. Aim Here, we tested if MC4R also contributes to leptin's effects on respiratory function. Methods After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119...
Gespeichert in:
Veröffentlicht in: | Acta Physiologica 2015-04, Vol.213 (4), p.893-901 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 901 |
---|---|
container_issue | 4 |
container_start_page | 893 |
container_title | Acta Physiologica |
container_volume | 213 |
creator | Bassi, M. Nakamura, N. B. Furuya, W. I. Colombari, D. S. A. Menani, J. V. do Carmo, J. M. da Silva, A. A. Hall, J. E. Colombari, E. |
description | Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin.
Aim
Here, we tested if MC4R also contributes to leptin's effects on respiratory function.
Methods
After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT), respiratory frequency (fR) and pulmonary ventilation (VE) were measured by whole‐body plethysmography during normocapnia or hypercapnia (7% CO2). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE, VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin‐cre) or only in proopiomelanocortin neurones (LepR/POMC‐cre) and in MC4R knockout (MC4R−/−) and wild‐type mice.
Results
Leptin (5 μg day−1) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day−1) increased body weight (~18%) and reduced ventilatory responses compared with control‐PBS group (Lep: 2119 ± 90 mL min−1 kg−1 and SHU9119: 997 ± 67 mL min−1 kg−1, vs. PBS: 1379 ± 91 mL min−1 kg−1). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min−1 kg−1). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin‐cre, LepR/POMC‐cre and MC4R−/− mice.
Conclusion
These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia. |
doi_str_mv | 10.1111/apha.12394 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4362918</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3623480551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5894-83e96153b3818cddb031995f9ca410ba8f9ed2399e88620a2fddfdc8dc2139cd3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EolXphh-AIrFBSCl-xIm9QRpV7QxSVViAKrGxHPuacUni1E4K8-_xMG0ELPDGj_vdo3t8EHpJ8BnJ650et_qMUCarJ-iYNJUoSUPqp8sZiyN0mtItxphQwipKn6MjyiluGimPUVyZyd_ryYehCK6YtlC0Ufuh6KHTQzAhTvmSdmmCvvCpiHA3-wi2cCEWHYy5WvrBziY_9cHO3SJlttCHCGn0UU8h7go3D2ZffIGeOd0lOH3YT9CXy4vP55vy6uP6w_nqqjRcyKoUDGRNOGuZIMJY22JGpOROGl0R3GrhJNjsW4IQNcWaOmudNcKabFMay07Q-4PuOLc9WAPDFHWnxuh7HXcqaK_-rgx-q76Fe1WxmkoissCbB4EY7mZIk-p9MtDlj4EwJ0Xqpma84Yxk9PU_6G2Y45DtZapmVGJOeabeHigTQ0oR3DIMwWqfptqnqX6nmeFXf46_oI_ZZYAcgB--g91_pNTq02b1KFoeenwO9OfSo-N3VTes4ermeq3W1zeXrNpI9ZX9Aj_MvHU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1663290525</pqid></control><display><type>article</type><title>Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bassi, M. ; Nakamura, N. B. ; Furuya, W. I. ; Colombari, D. S. A. ; Menani, J. V. ; do Carmo, J. M. ; da Silva, A. A. ; Hall, J. E. ; Colombari, E.</creator><creatorcontrib>Bassi, M. ; Nakamura, N. B. ; Furuya, W. I. ; Colombari, D. S. A. ; Menani, J. V. ; do Carmo, J. M. ; da Silva, A. A. ; Hall, J. E. ; Colombari, E.</creatorcontrib><description>Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin.
Aim
Here, we tested if MC4R also contributes to leptin's effects on respiratory function.
Methods
After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT), respiratory frequency (fR) and pulmonary ventilation (VE) were measured by whole‐body plethysmography during normocapnia or hypercapnia (7% CO2). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE, VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin‐cre) or only in proopiomelanocortin neurones (LepR/POMC‐cre) and in MC4R knockout (MC4R−/−) and wild‐type mice.
Results
Leptin (5 μg day−1) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day−1) increased body weight (~18%) and reduced ventilatory responses compared with control‐PBS group (Lep: 2119 ± 90 mL min−1 kg−1 and SHU9119: 997 ± 67 mL min−1 kg−1, vs. PBS: 1379 ± 91 mL min−1 kg−1). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min−1 kg−1). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin‐cre, LepR/POMC‐cre and MC4R−/− mice.
Conclusion
These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia.</description><identifier>ISSN: 1748-1708</identifier><identifier>EISSN: 1748-1716</identifier><identifier>DOI: 10.1111/apha.12394</identifier><identifier>PMID: 25207799</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; blood pressure ; Body Weight - drug effects ; Carbon Dioxide - blood ; central chemoreception ; Gene Expression Regulation ; hypercapnia ; Hypercapnia - chemically induced ; leptin ; Leptin - administration & dosage ; Leptin - pharmacology ; Male ; MC3/4 receptor ; melanocortin system ; Melanocortins - metabolism ; Melanocyte-Stimulating Hormones - administration & dosage ; Melanocyte-Stimulating Hormones - pharmacology ; Mice ; Mice, Knockout ; Rats ; Rats, Sprague-Dawley ; Receptor, Melanocortin, Type 3 - genetics ; Receptor, Melanocortin, Type 3 - metabolism ; Receptor, Melanocortin, Type 4 - genetics ; Receptor, Melanocortin, Type 4 - metabolism ; Respiratory Physiological Phenomena - drug effects</subject><ispartof>Acta Physiologica, 2015-04, Vol.213 (4), p.893-901</ispartof><rights>2014 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd</rights><rights>2014 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.</rights><rights>Copyright © 2015 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5894-83e96153b3818cddb031995f9ca410ba8f9ed2399e88620a2fddfdc8dc2139cd3</citedby><cites>FETCH-LOGICAL-c5894-83e96153b3818cddb031995f9ca410ba8f9ed2399e88620a2fddfdc8dc2139cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapha.12394$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapha.12394$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25207799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bassi, M.</creatorcontrib><creatorcontrib>Nakamura, N. B.</creatorcontrib><creatorcontrib>Furuya, W. I.</creatorcontrib><creatorcontrib>Colombari, D. S. A.</creatorcontrib><creatorcontrib>Menani, J. V.</creatorcontrib><creatorcontrib>do Carmo, J. M.</creatorcontrib><creatorcontrib>da Silva, A. A.</creatorcontrib><creatorcontrib>Hall, J. E.</creatorcontrib><creatorcontrib>Colombari, E.</creatorcontrib><title>Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function</title><title>Acta Physiologica</title><addtitle>Acta Physiol</addtitle><description>Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin.
Aim
Here, we tested if MC4R also contributes to leptin's effects on respiratory function.
Methods
After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT), respiratory frequency (fR) and pulmonary ventilation (VE) were measured by whole‐body plethysmography during normocapnia or hypercapnia (7% CO2). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE, VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin‐cre) or only in proopiomelanocortin neurones (LepR/POMC‐cre) and in MC4R knockout (MC4R−/−) and wild‐type mice.
Results
Leptin (5 μg day−1) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day−1) increased body weight (~18%) and reduced ventilatory responses compared with control‐PBS group (Lep: 2119 ± 90 mL min−1 kg−1 and SHU9119: 997 ± 67 mL min−1 kg−1, vs. PBS: 1379 ± 91 mL min−1 kg−1). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min−1 kg−1). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin‐cre, LepR/POMC‐cre and MC4R−/− mice.
Conclusion
These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia.</description><subject>Animals</subject><subject>blood pressure</subject><subject>Body Weight - drug effects</subject><subject>Carbon Dioxide - blood</subject><subject>central chemoreception</subject><subject>Gene Expression Regulation</subject><subject>hypercapnia</subject><subject>Hypercapnia - chemically induced</subject><subject>leptin</subject><subject>Leptin - administration & dosage</subject><subject>Leptin - pharmacology</subject><subject>Male</subject><subject>MC3/4 receptor</subject><subject>melanocortin system</subject><subject>Melanocortins - metabolism</subject><subject>Melanocyte-Stimulating Hormones - administration & dosage</subject><subject>Melanocyte-Stimulating Hormones - pharmacology</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Melanocortin, Type 3 - genetics</subject><subject>Receptor, Melanocortin, Type 3 - metabolism</subject><subject>Receptor, Melanocortin, Type 4 - genetics</subject><subject>Receptor, Melanocortin, Type 4 - metabolism</subject><subject>Respiratory Physiological Phenomena - drug effects</subject><issn>1748-1708</issn><issn>1748-1716</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS0EolXphh-AIrFBSCl-xIm9QRpV7QxSVViAKrGxHPuacUni1E4K8-_xMG0ELPDGj_vdo3t8EHpJ8BnJ650et_qMUCarJ-iYNJUoSUPqp8sZiyN0mtItxphQwipKn6MjyiluGimPUVyZyd_ryYehCK6YtlC0Ufuh6KHTQzAhTvmSdmmCvvCpiHA3-wi2cCEWHYy5WvrBziY_9cHO3SJlttCHCGn0UU8h7go3D2ZffIGeOd0lOH3YT9CXy4vP55vy6uP6w_nqqjRcyKoUDGRNOGuZIMJY22JGpOROGl0R3GrhJNjsW4IQNcWaOmudNcKabFMay07Q-4PuOLc9WAPDFHWnxuh7HXcqaK_-rgx-q76Fe1WxmkoissCbB4EY7mZIk-p9MtDlj4EwJ0Xqpma84Yxk9PU_6G2Y45DtZapmVGJOeabeHigTQ0oR3DIMwWqfptqnqX6nmeFXf46_oI_ZZYAcgB--g91_pNTq02b1KFoeenwO9OfSo-N3VTes4ermeq3W1zeXrNpI9ZX9Aj_MvHU</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Bassi, M.</creator><creator>Nakamura, N. B.</creator><creator>Furuya, W. I.</creator><creator>Colombari, D. S. A.</creator><creator>Menani, J. V.</creator><creator>do Carmo, J. M.</creator><creator>da Silva, A. A.</creator><creator>Hall, J. E.</creator><creator>Colombari, E.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TS</scope><scope>5PM</scope></search><sort><creationdate>201504</creationdate><title>Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function</title><author>Bassi, M. ; Nakamura, N. B. ; Furuya, W. I. ; Colombari, D. S. A. ; Menani, J. V. ; do Carmo, J. M. ; da Silva, A. A. ; Hall, J. E. ; Colombari, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5894-83e96153b3818cddb031995f9ca410ba8f9ed2399e88620a2fddfdc8dc2139cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>blood pressure</topic><topic>Body Weight - drug effects</topic><topic>Carbon Dioxide - blood</topic><topic>central chemoreception</topic><topic>Gene Expression Regulation</topic><topic>hypercapnia</topic><topic>Hypercapnia - chemically induced</topic><topic>leptin</topic><topic>Leptin - administration & dosage</topic><topic>Leptin - pharmacology</topic><topic>Male</topic><topic>MC3/4 receptor</topic><topic>melanocortin system</topic><topic>Melanocortins - metabolism</topic><topic>Melanocyte-Stimulating Hormones - administration & dosage</topic><topic>Melanocyte-Stimulating Hormones - pharmacology</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Melanocortin, Type 3 - genetics</topic><topic>Receptor, Melanocortin, Type 3 - metabolism</topic><topic>Receptor, Melanocortin, Type 4 - genetics</topic><topic>Receptor, Melanocortin, Type 4 - metabolism</topic><topic>Respiratory Physiological Phenomena - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bassi, M.</creatorcontrib><creatorcontrib>Nakamura, N. B.</creatorcontrib><creatorcontrib>Furuya, W. I.</creatorcontrib><creatorcontrib>Colombari, D. S. A.</creatorcontrib><creatorcontrib>Menani, J. V.</creatorcontrib><creatorcontrib>do Carmo, J. M.</creatorcontrib><creatorcontrib>da Silva, A. A.</creatorcontrib><creatorcontrib>Hall, J. E.</creatorcontrib><creatorcontrib>Colombari, E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta Physiologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bassi, M.</au><au>Nakamura, N. B.</au><au>Furuya, W. I.</au><au>Colombari, D. S. A.</au><au>Menani, J. V.</au><au>do Carmo, J. M.</au><au>da Silva, A. A.</au><au>Hall, J. E.</au><au>Colombari, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function</atitle><jtitle>Acta Physiologica</jtitle><addtitle>Acta Physiol</addtitle><date>2015-04</date><risdate>2015</risdate><volume>213</volume><issue>4</issue><spage>893</spage><epage>901</epage><pages>893-901</pages><issn>1748-1708</issn><eissn>1748-1716</eissn><abstract>Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin.
Aim
Here, we tested if MC4R also contributes to leptin's effects on respiratory function.
Methods
After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT), respiratory frequency (fR) and pulmonary ventilation (VE) were measured by whole‐body plethysmography during normocapnia or hypercapnia (7% CO2). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE, VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin‐cre) or only in proopiomelanocortin neurones (LepR/POMC‐cre) and in MC4R knockout (MC4R−/−) and wild‐type mice.
Results
Leptin (5 μg day−1) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day−1) increased body weight (~18%) and reduced ventilatory responses compared with control‐PBS group (Lep: 2119 ± 90 mL min−1 kg−1 and SHU9119: 997 ± 67 mL min−1 kg−1, vs. PBS: 1379 ± 91 mL min−1 kg−1). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min−1 kg−1). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin‐cre, LepR/POMC‐cre and MC4R−/− mice.
Conclusion
These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25207799</pmid><doi>10.1111/apha.12394</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1748-1708 |
ispartof | Acta Physiologica, 2015-04, Vol.213 (4), p.893-901 |
issn | 1748-1708 1748-1716 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4362918 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals blood pressure Body Weight - drug effects Carbon Dioxide - blood central chemoreception Gene Expression Regulation hypercapnia Hypercapnia - chemically induced leptin Leptin - administration & dosage Leptin - pharmacology Male MC3/4 receptor melanocortin system Melanocortins - metabolism Melanocyte-Stimulating Hormones - administration & dosage Melanocyte-Stimulating Hormones - pharmacology Mice Mice, Knockout Rats Rats, Sprague-Dawley Receptor, Melanocortin, Type 3 - genetics Receptor, Melanocortin, Type 3 - metabolism Receptor, Melanocortin, Type 4 - genetics Receptor, Melanocortin, Type 4 - metabolism Respiratory Physiological Phenomena - drug effects |
title | Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A30%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20the%20brain%20melanocortin%20system%20is%20required%20for%20leptin-induced%20modulation%20of%20chemorespiratory%20function&rft.jtitle=Acta%20Physiologica&rft.au=Bassi,%20M.&rft.date=2015-04&rft.volume=213&rft.issue=4&rft.spage=893&rft.epage=901&rft.pages=893-901&rft.issn=1748-1708&rft.eissn=1748-1716&rft_id=info:doi/10.1111/apha.12394&rft_dat=%3Cproquest_pubme%3E3623480551%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1663290525&rft_id=info:pmid/25207799&rfr_iscdi=true |